TY  - GEN
AU  - Sirima,Sodiomon B
AU  - Tiono,Alfred B
AU  - Ouédraogo,Alphonse
AU  - Diarra,Amidou
AU  - Ouédraogo,André Lin
AU  - Yaro,Jean Baptiste
AU  - Ouédraogo,Espérance
AU  - Gansané,Adama
AU  - Bougouma,Edith C
AU  - Konaté,Amadou T
AU  - Kaboré,Youssouf
AU  - Traoré,Abdoulaye
AU  - Chilengi,Roma
AU  - Roma,Chilengi
AU  - Soulama,Issiaka
AU  - Luty,Adrian J F
AU  - Druilhe,Pierre
AU  - Cousens,Simon
AU  - Nébié,Issa
TI  - Safety and immunogenicity of the malaria vaccine candidate MSP3 long synthetic peptide in 12-24 months-old Burkinabe children
SN  - 1932-6203
PY  - 2010///0312
KW  - Antigens, Protozoan
KW  - genetics
KW  - Burkina Faso
KW  - Child, Preschool
KW  - Dose-Response Relationship, Drug
KW  - Double-Blind Method
KW  - Humans
KW  - Infant
KW  - Malaria
KW  - prevention & control
KW  - Malaria Vaccines
KW  - therapeutic use
KW  - Merozoites
KW  - immunology
KW  - Peptides
KW  - chemistry
KW  - Plasmodium falciparum
KW  - metabolism
KW  - Protozoan Proteins
KW  - Research Design
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1371/journal.pone.0007549
ER  -